Patent Assignment
Reel/Frame 029834/0215
Change of Name
Recorded: 2013-02-19
Pages: 6
Assignor
ABBOTT BIOTHERAPEUTICS CORP
Executed: 2012-11-28
Assignee
ABBVIE BIOTHERAPEUTICS INC.
1500 SEAPORT BLVD, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(4)
Anti-CCR5 Antibody
Anti-CCR5 Antibody
Anti-CCR5 Antibody
Compositions Against Cancer Antigen Liv-1 and Uses Thereof
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 18, 2003
From: OLSON, WILLIAM C.; MADDON, PAUL J.
To: PROGENICS PHARMACEUTICALS, INC.
Reel/Frame 014393/0471 →
Assignment of Assignor's Interest
Aug 18, 2003
From: TSURUSHITA, NAOYA; HINTON, PAUL R.; VASQUEZ, MAXIMILLANO
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014392/0780 →
Change of Name
May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Assignment of Assignor's Interest
Mar 4, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022343/0275 →
Change of Name
Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Assignment of Assignor's Interest
Aug 28, 2012
From: LAW, DEBBIE; GISH, KURT
To: ABBOTT BIOTHERAPEUTICS CORP
Reel/Frame 028858/0959 →
Assignment of Assignor's Interest
Jan 15, 2013
From: PROGENICS PHARMACEUTICALS, INC.
To: CYTODYN, INC.
Reel/Frame 029633/0837 →